Prot # EMR 701165-024: A double-blind, randomized, placebo-controlled, parallel-group Phase II study to explore the potential beneficial effects of safinamide on cognition in non-demented patients with idiopathic Parkinson's disease (PD) and cognitive imp

Project: Research project

Project Details

StatusFinished
Effective start/end date12/16/102/15/12

Funding

  • EMD Serono, Inc. (EMR 701165-024)